Glucagon and Its Underutilization in Diabetes Self-Management: A Teachable Moment.

Abstract

Commentaries| July 08 2023 Glucagon and Its Underutilization in Diabetes Self-Management: A Teachable Moment Katherine Wolfe; Katherine Wolfe 1Department of Pharmacy, Spartanburg Medical Center, Spartanburg, SC Search for other works by this author on: This Site PubMed Google Scholar Jennifer Nicole Clements 0000-0003-2431-6651 Jennifer Nicole Clements 2Department of Nursing Administration, Spartanburg Regional Healthcare System, Spartanburg, SC Corresponding author: Jennifer Nicole Clements, jclements1027@outlook.com Search for other works by this author on: This Site PubMed Google Scholar Corresponding author: Jennifer Nicole Clements, jclements1027@outlook.com Clin Diabetes 2023;41(2):286–288 https://doi.org/10.2337/cd22-0015 Views Icon Views Article contents Figures & tables Video Audio Supplementary Data Peer Review Share Icon Share Facebook Twitter LinkedIn MailTo Cite Icon Cite Get Permissions Citation Katherine Wolfe, Jennifer Nicole Clements; Glucagon and Its Underutilization in Diabetes Self-Management: A Teachable Moment. Clin Diabetes 1 April 2023; 41 (2): 286–288. https://doi.org/10.2337/cd22-0015 Download citation file: Ris (Zotero) Reference Manager EasyBib Bookends Mendeley Papers EndNote RefWorks BibTex toolbar search Search Dropdown Menu toolbar search search input Search input auto suggest filter your search All ContentAll JournalsClinical Diabetes Search Advanced Search A woman with type 1 diabetes of 14 years’ duration is admitted to a noncritical care unit after presenting to the emergency center with hypoglycemia. According to her family member and emergency medical services personnel, the person’s blood glucose was noted to be 28 mg/dL. Pharmacy records indicate that her treatment regimen before admission included insulin glargine 40 units subcutaneously in the morning and insulin lispro 5 units subcutaneously before each meal, with a correction factor of 24 (1 unit of insulin for every 24 mg/dL above target) and that she received enough blood glucose monitoring supplies to perform four checks per day. Normal organ function is noted, and her A1C is found to have decreased from 9 to 6.2% in the past 3 months. During her 4-day hospitalization, her insulin therapy included insulin glargine 20 units subcutaneously in the morning and insulin lispro with a correction scale of 0–8... You do not currently have access to this content.